Basics Embecta Corp. IPO Date: April 1, 2022 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $684.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 2.17% Avg Daily Range (30 D): $0.26 | 1.89% Avg Daily Range (90 D): $0.26 | 1.88% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): .38M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 48 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 1,432 Avg Inst. Trade: $2.22M Avg Inst. Trade (30 D): $1.32M Avg Inst. Trade (90 D): $1.47M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.43M Avg Closing Trade (30 D): $1.32M Avg Closing Trade (90 D): $1.5M Avg Closing Volume: 115.12K     News Nov 25, 2025 @ 11:00 AM embecta Announces Quarterly Cash Dividend Source: Na Nov 17, 2025 @ 10:00 PM embecta announces changes to Board of Directors Source: Devdatt Kurdikar Nov 11, 2025 @ 10:00 PM embecta to Report Fiscal Fourth Quarter and Full Y... Source: Embecta Corp. Aug 26, 2025 @ 9:00 PM embecta to Participate in Investor Events Source: Embecta Corp. Aug 8, 2025 @ 10:00 AM embecta Announces Quarterly Cash Dividend Source: Christian Glazar Financials   TTM Q4 2025 FY 2025 Basic EPS $1.64 $.46 $1.64 Diluted EPS $1.62 $.44 $1.62 Revenue $ 1.08B $ 264M $ 1.08B Gross Profit $ 676.8M $ 158.5M $ 676.8M Net Income / Loss $ 95.4M $ 26.4M $ 95.4M Operating Income / Loss $ 242.1M $ 56.5M $ 242.1M Cost of Revenue $ 403.6M $ 105.5M $ 403.6M Net Cash Flow $ -44.3M $ -4.9M $ -44.3M PE Ratio 7.04